Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country’s ...
In response to rising demand for its popular diabetes and weight loss drug duo Mounjaro and Zepbound, Lilly has invested heavily to boost manufacturing capacity. With $27B plan to build 4 new ...
The 2.5 mg vial and 5 mg vial will be available at Rs 3,500 and Rs 4,375, respectively. A spokesperson said as Mounjaro ...
Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...
India Today on MSN3d
Mounjaro, popular weight-loss drug, launched in India. Here's how much it costsPopular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback